VARIZIG is a Intramuscular Solution in the Human Prescription Drug category. It is labeled and distributed by Aptevo Biotherapeutics Llc. The primary component is Human Varicella-zoster Immune Globulin.
Product ID | 70504-0126_bdb414f5-19f5-4d90-81f8-9b25e204fc1a |
NDC | 70504-0126 |
Product Type | Human Prescription Drug |
Proprietary Name | VARIZIG |
Generic Name | Varicella Zoster Immune Globulin (human) |
Dosage Form | Solution |
Route of Administration | INTRAMUSCULAR |
Marketing Start Date | 2016-07-01 |
Marketing Category | BLA / BLA |
Application Number | BLA125430 |
Labeler Name | Aptevo BioTherapeutics LLC |
Substance Name | HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN |
Active Ingredient Strength | 125 [iU]/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125430 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-07-01 |
Marketing Category | BLA |
Application Number | BLA125430 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-07-01 |
Ingredient | Strength |
---|---|
HUMAN VARICELLA-ZOSTER IMMUNE GLOBULIN | 125 [iU]/1 |
SPL SET ID: | c27a87e0-9953-4425-acec-16f7ed8ede64 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
53270-0126 | VARIZIG | Varicella Zoster Immune Globulin (Human) |
70257-126 | VariZig | Varicella Zoster Immune Globulin (Human) |
70504-0126 | VARIZIG | Varicella Zoster Immune Globulin (Human) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VARIZIG 78679351 3240650 Live/Registered |
SAOL INTERNATIONAL LIMITED 2005-07-27 |
VARIZIG 75934913 not registered Dead/Abandoned |
Cangene Corporation 2000-03-03 |